Here's Why Hologic (HOLX) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings?
HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift upcoming Q1 results.
HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now?
Hologic and Stryker gear up for earnings with diagnostic wins, surgical growth and strategic moves shaping the medical device race.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening
HOLX launches Ultimate Defense, a new U.S. campaign that urges routine Pap + HPV screening to boost awareness and help curb rising underscreening.
HOLX vs. SONVY: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?
HOLX or SONVY: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks?
HOLX vs. SONVY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks presents investors with the better value opportunity right now?
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead?
HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.
Hologic Trading Near 52-Week High: How Should You Play the Stock?
HOLX nears its 52-week high on diagnostics growth and AI adoption, while tariffs and challenges in China continue to pose risks.
Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth
HOLX's GYN Surgical unit gains momentum as the demand for gynecological devices rises globally, driven by innovation, M&A and strong overseas adoption.
